title: 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
authors.forename: Glenn N
authors.initials: GN
authors.lastname: Levine
authors.forename: Eric R
authors.initials: ER
authors.lastname: Bates
authors.forename: John A
authors.initials: JA
authors.lastname: Bittl
authors.forename: Ralph G
authors.initials: RG
authors.lastname: Brindis
authors.forename: Stephan D
authors.initials: SD
authors.lastname: Fihn
authors.forename: Lee A
authors.initials: LA
authors.lastname: Fleisher
authors.forename: Christopher B
authors.initials: CB
authors.lastname: Granger
authors.forename: Richard A
authors.initials: RA
authors.lastname: Lange
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Mack
authors.forename: Laura
authors.initials: L
authors.lastname: Mauri
authors.forename: Roxana
authors.initials: R
authors.lastname: Mehran
authors.forename: Debabrata
authors.initials: D
authors.lastname: Mukherjee
authors.forename: L Kristin
authors.initials: LK
authors.lastname: Newby
authors.forename: Patrick T
authors.initials: PT
authors.lastname: O'Gara
authors.forename: Marc S
authors.initials: MS
authors.lastname: Sabatine
authors.forename: Peter K
authors.initials: PK
authors.lastname: Smith
authors.forename: Sidney C
authors.initials: SC
authors.lastname: Smith
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Halperin
authors.forename: Glenn N
authors.initials: GN
authors.lastname: Levine
authors.forename: Sana M
authors.initials: SM
authors.lastname: Al-Khatib
authors.forename: Kim K
authors.initials: KK
authors.lastname: Birtcher
authors.forename: Biykem
authors.initials: B
authors.lastname: Bozkurt
authors.forename: Ralph G
authors.initials: RG
authors.lastname: Brindis
authors.forename: Joaquin E
authors.initials: JE
authors.lastname: Cigarroa
authors.forename: Lesley H
authors.initials: LH
authors.lastname: Curtis
authors.forename: Lee A
authors.initials: LA
authors.lastname: Fleisher
authors.forename: Federico
authors.initials: F
authors.lastname: Gentile
authors.forename: Samuel
authors.initials: S
authors.lastname: Gidding
authors.forename: Mark A
authors.initials: MA
authors.lastname: Hlatky
authors.forename: John S
authors.initials: JS
authors.lastname: Ikonomidis
authors.forename: José A
authors.initials: JA
authors.lastname: Joglar
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Pressler
authors.forename: Duminda N
authors.initials: DN
authors.lastname: Wijeysundera
mesh_terms: D026683:Advisory Committees; D000465:Algorithms; D000572:American Heart Association; D003324:Coronary Artery Disease / Q000188:drug therapy*; D054855:Drug-Eluting Stents; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States
chemical_list: D010975:Platelet Aggregation Inhibitors
keywords: AHA; P2Y(12) inhibitor; Scientific Statements; acute coronary syndrome; aspirin; coronary artery disease; coronary stents; dual antiplatelet therapy (DAPT); focused update; stable ischemic heart disease